Edgewise Therapeutics, Inc. EWTX 深 滬
等待開盤 09-20 09:30:00 美东时间
29.50
+10.430
+54.69%
華盛通- 最 高30.00
- 今 開25.75
- 成交量 1193.20万股
- 最 低 24.84
- 昨 收 19.07
- 總市值 27.47亿
- 52周最高 30.00
- 市盈率 靜 --
- 換手率 12.81%
- 52周最低 5.12
- 委 比 -97.58%
- 總股本 9311.06万
- 歷史最高 40.49
- 量 比 7.31
- 振 幅 27.06%
- 歷史最低 5.12
- 每 手 1
- 風險率 5.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美国OTC市场Advaxis, Inc.（ADXS.us）盘中异动 下午盘快速拉升5.00%
北京时间2024年09月20日03时16分，美国OTC市场Advaxis, Inc.（ADXS.us）股票出现波动，股价急速拉升5.00%。截至发稿，该股报0...
今天 03:16
Market-Moving News for September 19th
GLMD: 60% | Galmed Pharmaceuticals Plans To Broaden Its Drug Development Activities, Consisting Of Two Additional Programs Over The Next Two Years EWTX: 42% | Edgewise Therapeutics Announced Top-line Data
09-19 20:06
Edgewise rises after early trial results for heart disease therapy
Shares of Edgewise Therapeutics (NASDAQ:EWTX) climbed ~26% in the premarket on Thursday after the company, backed by topline results from Phase 1 and Phase 2 trials, announced plans to develop its hea...
09-19 19:25
Edgewise jumps ahead of “key stock-moving event”
Shares of Edgewise Therapeutics (NASDAQ:EWTX) added ~10% on Tuesday after Piper Sandler cited a potential catalyst related to the company’s experimental heart disease therapy, EDG-7500. EDG-7500, an o...
09-18 03:28
Dyne stock tumbles 31% amid drug updates, management changes
Shares of Dyne Therapeutics (NASDAQ:DYN) fell 31% Tuesday after the company released new data from a clinical trial called DELIVER for its drug DYNE-251 in the treatment of Duchenne muscular dystrophy...
09-04 04:48
Edgewise Therapeutics Unveils 2024 Equity Incentive Plan
Edgewise Therapeutics (EWTX) has provided an announcement. Edgewise Therapeutic...
08-13 05:29
JP Morgan Maintains Overweight on Edgewise Therapeutics, Raises Price Target to $31
JP Morgan analyst Tessa Romero maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Overweight and raises the price target from $30 to $31.
08-12 22:12
快讯 | Edgewise Therapeutics公司：摩根大通将目标价从30美元调高至31美元
Edgewise Therapeutics Inc : JP Morgan Raises Target Price to $31 From $30
08-12 12:33
快讯 | Edgewise Therapeutics报告2024年第二季度财务业绩及最近业务亮点
Edgewise Therapeutics Reports Second Quarter 2024 Financial Results and Recent ...
08-08 20:01
快讯 | Edgewise Therapeutics第二季度营业收入美元指数为-3810.7万
Edgewise Therapeutics Q2 Operating Income USD -38.107 Million
08-08 20:00
